priors.science/reviews/chronic-spontaneous-urticaria-treatment

Chronic Spontaneous Urticaria Treatment

The current evidence on 18 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

18claims tracked
61primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
3 Established · 9 Likely · 5 Uncertain · 0 Doubtful · 1 Refuted  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Omalizumab 300mg for refractory chronic spontaneous urticariaOmalizumabEstablished93%5
Remibrutinib reduces urticaria activity scoreBTK InhibitorsEstablished88%4
Urticaria relapses after cyclosporineImmunosuppressionEstablished88%4
Chronic spontaneous urticaria quality of life impairmentDisease BurdenLikely83%6
Barzolvolimab mast cell depletion in chronic spontaneous urticariaNovel BiologicsLikely79%4
BTK inhibitor versus omalizumab in chronic spontaneous urticariaBTK InhibitorsLikely78%4
IgE predicts omalizumab responseOmalizumabLikely75%5
H1 antihistamines first-line for chronic spontaneous urticariaAntihistamineLikely74%7
Type IIb autoimmune chronic spontaneous urticaria and omalizumabBiomarkersLikely74%6
Cyclosporine in omalizumab-refractory chronic spontaneous urticariaImmunosuppressionLikely73%5
Omalizumab versus cyclosporine on quality of lifeOmalizumabLikely73%5
Antihistamine updosing in refractory chronic spontaneous urticariaAntihistamineLikely71%4
Omalizumab relapse after withdrawalOmalizumabUncertain69%5
Dupilumab benefit in omalizumab-naive chronic spontaneous urticariaNovel BiologicsUncertain68%2
Chronic spontaneous urticaria spontaneous remission at five yearsDisease BurdenUncertain68%4
Basophil activation test identifies autoimmune chronic spontaneous urticariaBiomarkersUncertain60%4
Dupilumab benefit in omalizumab-refractory chronic spontaneous urticariaNovel BiologicsUncertain50%2
Ligelizumab superiority versus omalizumabNovel BiologicsRefuted10%2
Track Chronic Spontaneous Urticaria Treatment.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.